Format

Send to

Choose Destination
Med Care. 2010 Jun;48(6 Suppl):S9-16. doi: 10.1097/MLR.0b013e3181d99161.

Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects.

Author information

1
Health Policy Research Institute, Department of Medicine, University of California, Irvine, CA 92697, USA. skaplan@uci.edu

Abstract

BACKGROUND:

Interest in comparative effectiveness research and the rising number of negative or "small effect" trials have stimulated research into differential response to treatment among subgroups of patients.

OBJECTIVE:

To develop and test the Potential for Benefit Scale (PBS), a composite measure to identify subgroups of patients with differential potential for response to treatment, using diabetes as a model.

DESIGN:

Cross-sectional and longitudinal cohort study.

SUBJECTS AND SETTING:

Type 2 diabetes patients (n = 1361) were identified from 7 outpatient clinics serving a diverse population. Of these, 611 completed a 1-year follow-up.

MEASURES:

To represent patients' health status, we used the Total Illness Burden Index, the Physical Function Index of the SF-36, the Center for Epidemiologic Studies Depression Scale, and the Diabetes Burden Scale. To represent personality characteristics related to health, we used the Provider-Dependent Health Care Orientation scale. We assessed the contribution of these measures to a composite scale of patients' potential for treatment response in terms of self-reported medication adherence and glycemic control.

RESULTS:

Principal components analysis confirmed associations among these measures. The internal consistency reliability of the PBS was adequate (Cronbach alpha = 0.65). Patients in the lowest versus highest quartile of the PBS reported poorer adherence (18% vs. 55%, P < 0.001) and poorer glycemic control at baseline (mean hemoglobin A1c values: 7.75 vs. 7.39, P < 0.001). Those in the highest quartile of the PBS also were more likely to reach target values for glycemic control (HbA1c <7%) at 1-year follow-up, (adjusted OR = 1.61, P < 0.05).

CONCLUSIONS:

The PBS, a composite scale, may be helpful in identifying patients with differential potential for response to treatment.

PMID:
20473205
PMCID:
PMC5769476
DOI:
10.1097/MLR.0b013e3181d99161
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center